Therapeutic drug monitoring and clinical outcomes in severely ill patients receiving amoxicillin: a single-centre prospective cohort study
Christophe Marti, Angela Huttner(University Hospital of Geneva), Elodie von Dach(University Hospital of Geneva), Pierre Lescuyer(University Hospital of Geneva), Jérôme Stirnemann(Université Paris Cité), David Tonoli(University Hospital of Geneva)
Cited by 10
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
|Journal of Antimicrobial Chemotherapy|2015|262